Medical Digest & Congress Report

Professor Domenica Lorusso presented the overall survival results from the randomized, double-blind, phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study. Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer. Video: https://medicaldigest.org/scientific-contents/interview:pembrolizumab-plus-chemoradiotherapy-high-risk-locally-advanced-cervical-cancer-overall-survival-results...

Professor Josep Llovet discusses the results of LEAP-012 Study which he presented at ESMO 2024. Video: https://medicaldigest.org/scientific-contents/interview:leap-012-study-transarterial-chemoembolization-or-without-lenvatinib-pembrolizumab-intermediate-stage-hepatocellular-carcinoma

Professor Silke Gillessen discussing results from STAMPEDE trial assessing the addition of metformin to ADT for patients with mHSPC. Video: https://medicaldigest.org/scientific-contents/interview:adding-metformin-adt-patients-mhspc-overall-survival-results-multi-arm-multi-stage-randomized-platform-trial-stampede

Professor Silke Gillessen presented new results from the PEACE-3 trial at the 2024 ESMO conference. This study indicates that combining Enzalutamide with Radium223 significantly improves progression-free survival in patients with metastatic castration-resistant prostate cancer (mCRPC) and bone metastases over Enzalutamide alone. Video: https://medicaldigest.org/scientific-contents/interview:peace-...

Professor Peter Schmid presented the overall survival results from the phase 3 KEYNOTE-522 study at ESMO 2024 Congress. Neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for high-risk early-stage TNBC. Video: https://medicaldigest.org/scientific-contents/interview:neoadjuvant-pembrolizumab-or-placebo-plus-chemotherapy-followed-adjuvant-pembrolizum...

Professor Dominik P. Modest shares his thoughts on POD1UM-303/InterAACT 2 study, which are potentially practice-changing findings in squamous cell carcinoma of the anal canal. Video: https://medicaldigest.org/scientific-contents/interview:pod1um-303interaact-2-potentially-practice-changing-findings-scac-report-esmo2024

Professor Tony S.K. Mok shares his thoughts on setting a new benchmark for ALK+ aNSCLC targeted therapy. Video: https://medicaldigest.org/scientific-contents/interview:setting-new-benchmark-alk-ansclc-targeted-therapy-report-esmo2024

Professor Ann Partridge shares his thoughts on breast cancer, early stage highlights of the ESMO 2024 Congress. Video: https://medicaldigest.org/scientific-contents/interview:breast-cancer-early-stage-highlights-esmo-2024-congress

Professor Remi Nout shares his thoughts on the interim results of the phase 3 ENGOT-en11/GOG-3053/KEYNOTE-B21 trial that were presented during the ESMO Congress 2024. Video: https://medicaldigest.org/scientific-contents/interview:adjuvant-pembrolizumabchemotherapy-misses-dfs-end-point-high-risk-endometrial-cancer-benefits-dmmr-subgroup

Professor Remi Nout shares his thoughts on the treatment of cervical cancer in 2024 in the light of KEYNOTE-A18 study. Video: https://medicaldigest.org/scientific-contents/interview:treatment-cervical-cancer-2024-highlight-keynote-a18-study

Prof. Michael Böhm explains how SGLT-2 inhibitors became a strong pillar of treatment in HFrEF and HFpEF patients. Their antidiabetic effect and kidney protection make them a widely used tool in cardiovascular diseases. We learn where GLP-1 agonists stand in cardiovascular risk protection and how beneficial they are in overweight HFpEF patients. The new mineralocorticoid receptor antagonists (MRAs...

Prof. Carlos Robalo Cordeiro, immediate Past-President of the ERS shares his thoughts on the highlights of ERS 2024. Video: https://medicaldigest.org/scientific-contents/interview:highlihts-ers-2024-presidents-perspective

Prof. Michael Kreuter co-chaired a very interesting session at this years ERS congress on novelties in the treatement of interstitial lung diseases and pulmonary fibrosis. Video: https://medicaldigest.org/scientific-contents/interview:why-idiopathic-pulmonary-fibrosis-not-so-idiopathic-report-ers2024

Prof. Joan B. Soriano co-chaired a very interesting session at this years ERS congress on the challenges of increasing urbanisation for respiratory health and how to improve it in the 21st century. Video: https://medicaldigest.org/scientific-contents/interview:imroving-lung-health-21s-century

Prof. Ane Johannessen co-chaired an interesting session to identify how future city life around the world may have the potential to improve respiratory health. Video: https://medicaldigest.org/scientific-contents/interview:overcoming-challenges-increasing-urbanisation-respiratory-health

Prof. Maria Joana Pereira Catarata co-chaired a very interesting session on lung cancer diagnostics and treatment challenges. Video: https://medicaldigest.org/scientific-contents/interview:thoracic-oncology-lung-cancer-diagnostics-and-treatment-challenges

Prof. Charlotte Suppli Ulrik co-chaired a very interesting session at this years ERS congress on novel research data on asthma and chronic obstructive pulmonary disease management. Video: https://medicaldigest.org/scientific-contents/interview:novel-research-data-asthma-and-chronic-obstructive-pulmonary-disease-management-clinical-applications

Prof. Nick Hopkinson shares his thoughts on the challenges and management of COPD. Video: https://medicaldigest.org/scientific-contents/interview:copd-nutshell-ers2024

Prof. Andrew Bush co-chaired a very interesting session on the prevention and treatment of paediatric asthma. Video: https://medicaldigest.org/scientific-contents/interview:paediatric-asthma-2024-prevention-transition2

Dr. Alessandro Marcon on how to change urban areas to improve the life of allergic patients? Video: https://medicaldigest.org/scientific-contents/interview:how-change-urban-areas-improve-life-allergic-patients

Prof. Angela Zacharasiewicz shares her thoughts on the prevention and treatment of paediatric asthma. To find out more, visit the Children's Bronchiectasis Education, Advocacy and Research Network: https://www.improvebe.org/ Video: https://medicaldigest.org/scientific-contents/interview:paediatric-asthma-2024-prevention-transition

Prof. Nick Hopkinson on the goal of a smoke-free generation. Video: https://medicaldigest.org/scientific-contents/interview:smoke-free-europe-utopia-or-feasible-reality

Prof. Joanna Chorostowska-Wynimko, President Elect of the European Respiratory Society gave us a brief summary on the state-of-the-art respiratory medicine against lung cancer. Video: https://medicaldigest.org/scientific-contents/interview:state-art-molecular-diagnostics-lung-cancer-pulmonologist-report-ers2024

Professor Marc Bonaca explains what is the benefit of starting earlier PCSK9 inhibitors for acute coronary syndromes? Video: https://medicaldigest.org/scientific-contents/interview:what-benefit-starting-earlier-pcsk9-inhibitors-acute-coronary-syndromes-report-esc202 4

Professor Antonio Ceriello co-chaired a very interesting session on prediabetes. He shared his thoughts on the field with us. Video: https://medicaldigest.org/scientific-contents/interview:pre-diabetes-risk-factor-cardiovascular-disease-report-esc2024